What does “Entresto” cost in Europe, and which countries sell it?
Entresto (sacubitril/valsartan) is approved and marketed in multiple European countries, but prices and availability vary by country because each health system sets its own pricing and reimbursement rules. If you tell me which country (for example, UK, Germany, France, Italy, Spain, or Netherlands), I can narrow the answer to that market.
Where can patients get Entresto in Europe?
In Europe, Entresto is typically dispensed through national healthcare channels (hospital or community pharmacies depending on local rules) with reimbursement or coverage that depends on eligibility criteria set by each country’s payer system.
Is Entresto available as a generic in Europe yet?
Entresto is usually protected by patent and exclusivity in many European markets, which is why generics and biosimilar-style substitutes are not typically available immediately. Patent status can differ by country, so availability can change depending on the exact European jurisdiction.
For up-to-date patent and exclusivity timelines by country, DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/ (search “Entresto” there). [1]
Why would availability differ across European countries?
The main reasons are country-by-country:
- Approval and labeling terms (which indications and dosing schedules)
- Reimbursement decisions and restrictions
- Patent and exclusivity status (which affects when competitors can enter)
Which exact “Entresto” question do you mean: price, prescription access, or whether it’s generic?
If you reply with your target country in Europe and what you need (price, how to get it, or whether there’s a cheaper alternative/generic), I’ll tailor the answer to that specific question.
Sources
- DrugPatentWatch.com